Last updated: 27 January 2023 at 4:56pm EST

Quentin Mc Cubbin Net Worth




The estimated Net Worth of Quentin Mc Cubbin is at least 35.5 千$ dollars as of 5 July 2022. Quentin Cubbin owns over 17,500 units of Frequency Therapeutics Inc stock worth over 13,473$ and over the last 4 years Quentin sold FREQ stock worth over 21,982$.

Quentin Cubbin FREQ stock SEC Form 4 insiders trading

Quentin has made over 5 trades of the Frequency Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently Quentin exercised 17,500 units of FREQ stock worth 5,250$ on 5 July 2022.

The largest trade Quentin's ever made was exercising 17,500 units of Frequency Therapeutics Inc stock on 5 July 2022 worth over 5,250$. On average, Quentin trades about 5,615 units every 46 days since 2021. As of 5 July 2022 Quentin still owns at least 44,909 units of Frequency Therapeutics Inc stock.

You can see the complete history of Quentin Cubbin stock trades at the bottom of the page.



What's Quentin Cubbin's mailing address?

Quentin's mailing address filed with the SEC is 75 HAYDEN AVE, SUITE 300, LEXINGTON, MA, 02421.

Insiders trading at Frequency Therapeutics Inc

Over the last 5 years, insiders at Frequency Therapeutics Inc have traded over 11,017,122$ worth of Frequency Therapeutics Inc stock and bought 369,233 units worth 5,339,982$ . The most active insiders traders include Joel S MarcusRobert LangerMarc A Cohen. On average, Frequency Therapeutics Inc executives and independent directors trade stock every 11 days with the average trade being worth of 3,858$. The most recent stock trade was executed by Richard J. Mitrano on 18 August 2023, trading 464 units of FREQ stock currently worth 269$.



What does Frequency Therapeutics Inc do?

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.



Complete history of Quentin Cubbin stock trades at Frequency Therapeutics Inc

インサイダー
取引
取引
合計金額
Quentin Mc Cubbin
Chief Manufacturing Officer
オプション行使 26,775$
5 Jul 2022
Quentin Mc Cubbin
Chief Manufacturing Officer
販売 11,052$
18 Feb 2022
Quentin Mc Cubbin
Chief Manufacturing Officer
販売 10,930$
16 Feb 2022
Quentin Mc Cubbin
Chief Manufacturing Officer
オプション行使 74,900$
14 Feb 2022
Quentin Mc Cubbin
Chief Manufacturing Officer
購入する 88,500$
17 May 2021


Frequency Therapeutics Inc executives and stock owners

Frequency Therapeutics Inc executives and other stock owners filed with the SEC include: